NDC 24208-446

Besivance

Besifloxacin

Besivance is a Ophthalmic Suspension in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Besifloxacin.

• Product ID: 24208-446_557f4ed7-1141-47cc-a653-3d8f5fb1eb4a
• NDC: 24208-446
• Product Type: Human Prescription Drug
• Proprietary Name: Besivance
• Generic Name: Besifloxacin
• Dosage Form: Suspension
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2009-05-28
• Marketing Category: NDA / NDA
• Application Number: NDA022308
• Labeler Name: Bausch & Lomb Incorporated
• Substance Name: BESIFLOXACIN
• Active Ingredient Strength: 6 mg/mL
• Pharm Classes: Quinolone Antimicrobial [EPC],Quinolones [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 24208-446-02

1 BOTTLE, DROPPER in 1 CARTON (24208-446-02) > 2 mL in 1 BOTTLE, DROPPER

• Marketing Start Date: 2009-05-28
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 24208-446-05 [24208044605]

Besivance SUSPENSION

• Marketing Category: NDA
• Application Number: NDA022308
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2009-05-28

NDC 24208-446-02 [24208044602]

Besivance SUSPENSION

• Marketing Category: NDA
• Application Number: NDA022308
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-05-28

Drug Details

Active Ingredients

Ingredient	Strength
BESIFLOXACIN	6 mg/mL

OpenFDA Data

• SPL SET ID: a3e6d688-7e5e-4ca3-b27e-79756c322a32
• Manufacturer:
  • Bausch & Lomb Incorporated
• UNII:
  • BFE2NBZ7NX
• RxNorm Concept Unique ID - RxCUI:
  • 850309
  • 850305

Pharmacological Class

• Quinolone Antimicrobial [EPC]
• Quinolones [CS]

Medicade Reported Pricing

24208044605 BESIVANCE 0.6% SUSP

Pricing Unit: ML | Drug Type:

NDC Crossover Matching brand name "Besivance" or generic name "Besifloxacin"

NDC	Brand Name	Generic Name
24208-446	Besivance	Besifloxacin
50090-1241	Besivance	Besifloxacin